Johor Corporation president and chief executive, Syed Mohamed Syed Ibrahim, said these partnerships aim to drive medical innovation, workforce development and specialised training within the KPJ Health System.

“By integrating expertise from leading academic and industry players, we are not only strengthening our university’s capabilities, but also ensuring that our hospitals continue to be at the forefront of patient care and medical innovation,” Syed Mohamed, who is also the KPJU chairman, said in a statement.

The partnerships were formalised at the event “Partnerships for Impact: Advancing Health Through Education & Research”, officiated on Feb 20 by higher education minister Zambry Abdul Kadir.

Also present were higher education director-general Azlinda Azman and KPJU chancellor Sharifah Hapsah Syed Hasan Shahabudin.

The collaborations focus on key areas, including AI-driven health technologies, early disease detection, regenerative medicine and precision medicine.

“Among the key collaborations, TrustR is leveraging AI to enhance biomarker measurements for early disease detection, while Arcadia Life Sciences is pioneering non-invasive screening for early colon cancer.

“In regenerative medicine, KPJU is working with Supergenics Life Sciences on clinical trials, exploring stem cell therapy for stroke recovery,” said the statement.

Additionally, KPJU has joined forces with Universiti Kebangsaan Malaysia (UKM) and Universiti Teknologi Mara (UiTM) to advance precision medicine, disease prevention and optimised treatment strategies.

KPJU has also introduced a leadership programme in collaboration with the University of Melbourne and Singapore Management University to equip healthcare executives with strategic expertise.

The event also saw KPJU unveiling its new logo, symbolising its commitment to excellence in healthcare education and research.